Skip to main content
. 2022 May 13;2022(5):CD013525. doi: 10.1002/14651858.CD013525.pub2

Avraham 2012.

Study characteristics
Methods Prospective, double‐blind, randomised, controlled study
Participants 61 (29 Ibuprofen, 32 placebo)
61 women who underwent first‐trimester termination of pregnancy (29 Ibuprofen, 32 placebo)
Interventions Women received 600 mg mifepristone orally, followed by 400 μg oral misoprostol 2 days later. They were randomised to receive pre‐emptively 2 tablets of 400 mg ibuprofen orally or a placebo, when taking the misoprostol. The women completed a questionnaire about side effects and pain score and returned for an ultrasound follow‐up examination 10‐14 days after the medical abortion.
Outcomes Pain score, GI side effects, complete abortion rate
Notes Trial registration: NCT00997074 (prospective)
Dates: October 2009‐October 2010
Funding: not reported
Conflicts of Interest: none disclosed
Contact attempted to gather missing data – no response